Next Gen Aesthetic Filler
Albumin-Based Injectable Filler Candidate in Development
AlbuDerm’s lead program is an albumin-based aesthetic medical filler, currently in preclinical development. It is being designed as a biostimulator filler intended to provide structural support and controlled integration, aligned with established aesthetic injection workflows. No AlbuDerm product is approved for clinical use.
Medical Filler
Why Albumin?
Recombinant human albumin is a well-characterized protein with a long history of medical use in other contexts. As a biomaterial scaffold, albumin offers a promising foundation for next generation injectable fillers.
Key Design Advantages
Human Protein-BasedScaffold
Tunable MechanicalProperties
Degradation ProfileUnder Evaluation
FormulationFlexibility
(All attributes refer to design intent and preclinical development goals.)
Product Concept
The AlbuDerm Aesthetic Filler Concept Is Being Developed To:
Align with existing injection techniques
Support structural refinement in key facial areas
Enable predictable handling and syringeability
Integrate with real world clinical workflows
Areas of Intended Application (Conceptual)
Nasolabial Folds
Marionette Lines
Cheek Volume
Lips
Chin Contour
Under-Eye Hollows
Temple Volume
These represent conceptual areas of intended use for future clinical evaluation.